Grant

Therapeutic Targeting of 5HT1F Receptor-Mediated Mitochondrial Biogenesis To Address Parkinson?s Disease

Sponsored by Michael J. Fox Foundation for Parkinson's Research

Active

$499.9K Funding

2 People

External

Related Topics

parkinson's disease, therapeutic targeting, 5-ht1f receptor, mitochondrial biogenesis, neurodegenerative diseases

People

Rick Schnellmann
Co-Investigator (COI)
Pharmacology and Toxicology﹒Dean
Lalitha Madhavan
Principal Investigator (PI)
Neurology﹒Associate Professor